跳至主要内容
临床试验/CTRI/2020/04/024581
CTRI/2020/04/024581招募中2 期

Randomized Controlled Clinical Study to Evaluate the Safety and Efficacy of Hijamah Bil-Shart in Cervical Radiculopathy

Jamia Hamdard0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
Jamia Hamdard

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of cervical radiculopathy in the age-group of 30-60 years.
  • Patients of all genders.
  • Patients with signs and symptoms of cervical spondylosis with radiculopathy; and radiological changes suggestive of the disease.(McDonald M A; Kirsch F E; et al., 2019)
  • Cervical radiculopathy diagnosed by positive response to at least one of the four Upper Limb Tension Tests; with symptoms of cervical radiculopathy for less than 6 months. (Thoomes, et al., 2018)
  • Pain intensity score of 30-60 mm on a 100-mm visual analog scale (VAS)
  • Willingness to give informed consent.

排除标准

  • Pregnant and lactating women.
  • Any history of cardiac, hepatic, renal diseases.
  • History of spinal whiplash injury / fracture.
  • History of any spinal surgery.
  • Patients taking NSAIDs or corticosteroids (Washout period : NSAIDs - 01 week; Corticosteroids - 6 weeks).
  • Known cases of any other disease of cervical spine like Ankylosing spondylitis, any Vascular lesions, Neoplasms and myelopathy.
  • Patients taking any non-pharmacological therapy for the same complaint in the past 4 weeks. (eg. Acupuncture, Hijamah, physiotherapy etc.).
  • Patients of bleeding disorders/ anaemia (Hb ââ?°Â¤ 9gm %). Patients taking Anti-coagulants.
  • HIV/AIDS, HCV and HBsAg positive patients.
  • Patients with uncontrolled Diabetes mellitus (HbA1C >7%) and hypertension (Systolic >129 mm Hg, Diastolic > 89 mm Hg).
  • Alcoholic patients, tobacco users.

研究者

发起方
Jamia Hamdard

相似试验